News About: Pharm. Industry
Fosamax 70mg shown to be effective in the increase of bone mass density
MSD Korea said that Fosamax inj. was shown to be more effective in the increase of bone mass density, compared with risedronate, according to the recent session of the World Osteoporosis Association which was held in ...
Hanmi registered novel process patent for Paclitaxel in Japan.
Hanmi pharmaceutical company announced on May 15 that a novel process patent for Paclitaxel, an anti-cancer drug, had been successfully registered in Japan, claiming that this process showed far higher yield with puri...
Establishment for PL task force working committee eyed
With the forthcoming implementation of product liability (PL) in July 1, the Korean Pharmaceutical Manufacturers Association (KPMA) says that a PL task force working committee will be newly established from this June,...
KPMA to call for drug related fair transaction order
Chairman Kim Chung-soo, a chairman of both KPMA and Fair Competition Committee, has called for more fair competition order by sending his petition letters to all KPMA members on May 10, after holding the working commi...
Milican inj. to be listed as medical insurance drug in JulyThe Ministry of Health and Welfare (MOHW) has announced that Milican inj. of Dongwha Pharm, a new radioactive drug indicated in the treatment of liver cancer, will be listed as ...
|
Daewoong Pharm to contemplate split off
Daewoong Pharm says that based on the report of Samil Accounting Corporation, it is now contemplating a split off plan to be finalized next month, in a bid to cope with the rapidly changing market environment and prom...
GSK and Gilead Sciences to execute a strategic license agreement for antiviral agentr
GlaxoSmithKline says that it signed with Gilead Sciences a strategic license agreement for the commercialization of antiviral agent (adefovir dipivoxil). Adefovir dipivoxil tablet (10mg once daily) for the treatment o...
Graft offering and reception culture intended for doctors rampant in foreign invested firm
In the recent survey of it own members on the fair competition released by the Korea Research Based Pharmaceutical Industry Association (KRPIA), 42 medical representatives of foreign invested firms has disclosed that ...
Domestic market for children health foods will mark 100 billion won this year
Pharmaceutical business sources say that thanks much to incessant launching of new products and fierce competitions among drug firms and large health foods makers using various distribution channels, the domestic mark...
Uprima of Abbott found to be safe in patients with cardiac disorder
In the recent forum in Hong Kong, the data of 500 doctors from several countries of Pacific-rim countries, Asia and Africa demonstrated that Uprima of Abbbott had a better tolerability in patients with impotence takin...
